EXHIBIT 31.2

                  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
                       PURSUANT TO RULES 13a-14 AND 15d-14
                     OF THE SECURITIES EXCHANGE ACT OF 1934

         I, Wenjun Jiao,  Chief Financial  Officer of Tiens Biotech Group (USA),
Inc. (the "Registrant"), certify that:

         1. I have reviewed this quarterly  report on Form 10-QSB for the period
ended September 30, 2005, of the Registrant.

         2. Based on my  knowledge,  this  report  does not  contain  any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report.

         3. Based on my knowledge, the financial statements, and other financial
information included in the report,  fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Registrant as
of, and for, the periods, presented in the report.

         4. The other certifying  officer and I are responsible for establishing
and maintaining  disclosure  controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules  13a-15(f) and  15d-15(f))  for the Registrant and
have:

                  a. Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under my supervision,  to
ensure that  material  information  relating to the  Registrant,  including  its
consolidated subsidiaries,  is made known to me by others within those entities,
particularly during the period in which this report is being prepared;

                  b. Evaluated the effectiveness of the Registrant's  disclosure
controls and procedures and presented in this report our  conclusions  about the
effectiveness  of the disclosure  controls and procedures,  as of the end of the
period covered by this report based on such evaluation; and

                  c.  Disclosed  in this  report any change in the  Registrant's
internal control over financial  reporting that occurred during the Registrant's
most recent fiscal quarter (the  Registrant's  fourth fiscal quarter in the case
of an annual report) that has materially  affected,  or is reasonably  likely to
materially affect, the Registrant's internal control over financial reporting.

         5. The  Registrant's  other  certifying  officer and I have  disclosed,
based  on  our  most  recent  evaluation  of  internal  control  over  financial
reporting,  to  the  Registrant's  auditors  and  the  audit  committee  of  the
Registrant's board of directors (or persons fulfilling the equivalent function):


                  a. All significant deficiencies and material weaknesses in the
design or  operation  of internal  control over  financial  reporting  which are
reasonably  likely to  adversely  affect  the  Registrant's  ability  to record,
process, summarize and report financial information; and

                  b.  Any  fraud,   whether  or  not  material,   that  involves
management or other  employees who have a significant  role in the  Registrant's
internal control over financial reporting.


Dated:  November 14, 2005                       By: /s/ Wenjun Jiao
                                                   -----------------------------
                                                   Wenjun Jiao
                                                   Chief Financial Officer
                                                   (Principal Financial Officer)